Risankizumab (anti-IL-23)

製品コード：A2046         Batch: A204602

印刷

Risankizumab targets the p19 subunit of IL-23. Risankizumab is indicated for the treatment of psoriasis and is safe and effective in maintaining remission in active Crohn's disease.

製品説明

CAS No. 1612838-76-2
Formulation PBS Buffer, PH 7.4
Isotype human IGg1, κ
Application Risankizumab (anti-IL-23)
Source CHO
Storage
(From the date of receipt)		 Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
Shipping Shipped under low temperature conditions
Purity 99%
Protein concentration 15.71mg/ml
Endotoxin Level ＜1EU/mg

カスタマーフィードバック

人間や獣医の診断であるか治療的な使用のためにでない。